Synthesis and cytotoxic activity evaluation of some new 1, 3, 4-oxadiazole, 1, 3, 4-thiadiazole and 1, 2, 4- triazole derivatives attached to phthalimide

Farshid Hassanzadeh , Elham Jafari , Hojjat Sadeghi-Aliabadi


Background and purpose: In the last few decades, nitrogen-rich heterocyclic compounds such as 1, 3,                 4-thiadiazoles, 1, 2, 4-triazoles and 1, 3, 4-oxadiazoles have received considerable attention because of their notable biological properties, especially cytotoxic effects. The small molecules of mentioned azole derivatives revealed very intensive antitumor activity. In addition, phthalimide-thiadiazole and naphthalimide-triazole hybrid derivatives have shown remarkable cytotoxic effects. According to these observations, some of the hybrid derivatives containing the phthalimide-five-membered azoles were prepared in three steps in this research.

Experimental approach: The thiol group of azoles was treated with ethyl chloroacetate which was followed by a reaction with hydrazine hydrate to provide acid hydrazide derivatives. Subsequently, the corresponding acid hydrazides were utilized to prepare the final derivatives through the reaction with phthalic anhydride. Cytotoxic activity of final compounds was evaluated against MCF-7 and HeLa cell lines using MTT assay.

Findings/Results: Compound 3d containing two phthalimide moieties in its structure showed a significant improvement in cytotoxic activity with an IC50 value of 29 µM against HeLa cell line. Compounds 3a-3c showed less cytotoxic effects against both cell lines.

Conclusion and implications: The combination of the thiadiazole nucleus with two phthalimide structures increased the cytotoxic activity against the HeLa cell line. This increase in cytotoxic activity is probably due to its being more lipophilic characteristic and interaction of this derivative with the biological targets of two directions.




Keywords: Cytotoxic activity; Phthalimide; 1, 3, 4-Oxadiazole; 1, 3, 4-Thiadiazole; 1, 2, 4-Triazole.

Full Text:



Ramazani A, Khoobi M, Torkaman A, Nasrabadi FZ, Forootanfar H, Shakibaie M, et al. One-pot, four-component synthesis of novel cytotoxic agents 1-(5-aryl-1,3,4-oxadiazol-2-yl)-1-(1H-pyrrol-2-yl) methanamines. Eur J Med Chem. 2014;78:151-156.

DOI: 10.1016/j.ejmech.2014.03.049.

Bajaj S, Asati V, Singh J, RoyPP.1,3,4-Oxadiazoles: an emerging scaffold to target growth factors, enzymes and kinases as anticancer agents. Eur J Med Chem. 2015;97:124-141.

DOI: 10.1016/j.ejmech.2015.04.051.

Singh AK, Sahu VK, Yadav D. Biological activities of 2,5-disubstituted-1,3,4-oxadiazoles. Int J Pharm Sci Res. 2011;2(6):135-147.

Jafari E, Mohammadi T, Jahanian-Najafabadi A, HassanzadehF. Synthesis and antimicrobial evaluation of some 2,5 disubstituted 1,3,4-oxadiazole derivatives. Res Pharm Sci. 2017;12(4):330-336.

DOI: 10.4103/1735-5362.212051.

Hassanzadeh F, Sadeghi-Aliabadi H, Jafari E, Sharifzadeh A, DanaN. Synthesis and cytotoxic evaluation of some quinazolinone-5-(4-chlorophenyl) 1,3,4-oxadiazole conjugates. Res Pharm Sci. 2019;14(5):408-413.

DOI: 10.4103/1735-5362.268201.

Sun J, Zhu H, Yang ZM, ZhuHL. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2 (3H)-thione quinolone derivatives as novel anticancer agent. Eur J Med Chem. 2013; 60:23-28.

DOI: 10.1016/j.ejmech.2012.11.039.

Shi YJ, Song XJ, Li X, Ye TH, Xiong Y, YuLT. Synthesis and biological evaluation of 1,2,4-triazole and 1,3,4-thiadiazole derivatives as potential cytotoxic agents. Chem Pharm Bull (Tokyo). 2013;61(11):1099-1104.

DOI: 10.1248/cpb.c13-00242.

Yang SJ, Lee SH, Kwak HJ, GongYD. Regioselective synthesis of 2-amino-substituted 1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives via reagent-based cyclization of thiosemicarbazide intermediate. J Org Chem. 2013;78(2):438-444.

DOI: 10.1021/jo302324r.

Waghamale S, PisteP. Pharmacological activities of triazole, oxadiazole and thiadiazole. Int J Pharm Bioorg Sci. 2013;4(3):310-332.

Ahmad A, Varshney H, Rauf A, Sherwani A, Owais M. Synthesis and anticancer activity of long chain substituted 1, 3, 4-oxadiazol-2-thione, 1, 2, 4-triazol-3-thione and 1, 2, 4-triazolo [3, 4-b]-1, 3, 4-thiadiazine derivatives. Arabian J Chem. 2017;10:S3347-S3357.

DOI: org/10.1016/j.arabjc.2014.01.015.

El-Hamouly WS, Amin KM, El-Assaly SA, El-MeguidEAA. Synthesis and antitumor activity of some new 1,3,4-oxadiazole, pyrazole and pyrazolo [3,4-d] pyrimidine derivatives attached to 4-benzothiazol-2-yl phenyl moiety. Der Pharma Chem. 2011;3(6):282-292.

Zhang K, Wang P, Xuan LN, Fu XY, Jing F, Li S, et al. Synthesis and antitumor activities of novel hybrid molecules containing 1,3,4-oxadiazole and 1,3,4-thiadiazole bearing Schiff base moiety. Bioorg Med Chem Lett. 2014;24(22):5154-5156.

DOI: 10.1016/j.bmcl.2014.09.086.

Bhinder CK, KaurA. Review: 1,3,4-oxadiazole as anticancer agent. Int J Pharm Res Sci. 2014;3(4):457-479

Bondock S, Adel S, Etman HA, Badria FA. Synthesis and antitumor evaluation of some new 1,3,4oxadiazole-based heterocycles. Eur J Med Chem. 2012;48:192-199.

DOI: 10.1016/j.ejmech.2011.12.013

Zhang F, Wang XL, Shi J, Wang SF, Yin Y, Yang YS, et al. Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio) acetohydrazide derivatives as potential anticancer agents. Bioorg Med Chem. 2014;22(1):468-477.

DOI: 10.1016/j.bmc.2013.11.004.

Mavrova AT, Wesselinova D, Tsenov YA, DenkovaP. Synthesis, cytotoxicity and effects of some 1,2,4-triazole and 1,3,4-thiadiazole derivatives on immunocompetent cells. Eur J Med Chem. 2009;44(1):63-69.

DOI: 10.1016/j.ejmech.2008.03.006.

Radi M, Crespan E, Botta G, Falchi F, Maga G, Manetti F, et al. Discovery and SAR of 1,3,4thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. Bioorg Med Chem Lett. 2008;18(3):1207-1211.

DOI: 10.1016/j.bmcl.2007.11.112.

Aliabadi A, Eghbalian E, Kiani A. Synthesis and evaluation of the cytotoxicity of a series of 1, 3, 4-thiadiazole based compounds as anticancer agents. Iran J Basic Med Sci. 2013;16(11):1133-1138.

PMID: 24494064.

Hassanzadeh F, Sadeghi-Aliabadi H, Nikooei S, Jafari E, VaseghiG. Synthesis and cytotoxic evaluation of some derivatives of triazole-quinazolinone hybrids. Res Pharm Sci. 2019;14(2):130-137.

DOI: 10.4103/1735-5362.253360.

Jafari E, Taghi jarah-Najafabadi N, Jahanian-Najafabadi A, Poorirani S, Hassanzadeh F, Sadeghian-RiziS. Synthesis and evaluation of antimicrobial activity of cyclic imides derived from phthalic and succinic anhydrides. Res Pharm Sci. 2017;12(6):526-534.

DOI: 10.4103/1735-5362.217433.

Hassanzadeh F, JafariE. Cyclic imide derivatives: as promising scaffold for the synthesis of antimicrobial agents. J Res Med Sci. 2018;23:53-59.

DOI: 10.4103/jrms.JRMS_539_17.

Al-Azzawi AM, HamdAS. Synthesis, characterization and antimicrobial activity evaluation of new cyclic imides containing 1,3,4-thiadiazole and 1,3,4-oxadiazole moieties. Int J Res Pharm Chem. 2013;3:890-897.

Sondhi SM, Rani R, Roy P, Agrawal SK, SaxenaAK. Microwave-assisted synthesis of N-substituted cyclic imides and their evaluation for anticancer and anti-inflammatory activities. Bioorg Med Chem Lett. 2009;19(5):1534-1538.

DOI: 10.1016/j.bmcl.2008.07.048.

Shankaraiah N, Kumar NP, Tokala R, Gayatri BS, Talla V, SantosLS. Synthesis of new 1,2,3-triazolo-naphthalimide/phthalimide conjugates via ‘Click' reaction: DNA intercalation and cytotoxic studies. J Braz Chem Soc. 2019;30(3):454-461.

DOI: 10.21577/0103-5053.20180111.

Kushwaha N, Kaushik D. Recent advances and future prospects of phthalimide derivatives. J App Pharm Sci. 2016;6(3): 159-171.


Rezaei Z, Moghimi S, Javaheri R, Asadi M, Mahdavi M, Shabani S, et al. Synthesis and biological evaluation of 1,3,4-thiadiazole linked phthalimide derivatives as anticancer agents. Lett Drug Des Discov.2017;14(10): 1138-1144.

DOI: 10.2174/1570180814666170127164759.

CavusogluBK, Yurttaş L, CantŘrkZ. The synthesis, antifungal and apoptotic effects of triazole-oxadiazoles against Candida species. Eur J Med Chem. 2018;144:255-261.

DOI: 10.1016/j.ejmech.2017.12.020.

RehmanAU, Rasool S, Abbasi MA, Siddiqui SZ, Sattar A, Khan KM, et al. Synthesis, characterization and biological activity of some new S-substituted derivatives of 5-(2-chlorophenyl)-1,3,4-oxadiazol-2-thiol. J Chem Soc Pak. 2015;37(4):776-786.

RasoolS, Rehman AU, Abbasi MA, Siddiqui SZ, Shah SAA, Ahmad I, et al. Antibacterial and enzyme inhibition screening of some new acetamide and azomethine derivatives. J Chil Chem Soc. 2015;60(4):2704-2710.

DOI: 10.4067/S0717-97072015000400014.

Popiołek Ł, Kosikowska U, Mazur L, Dobosz M, MalmA. Synthesis and antimicrobial evaluation of some novel 1,2,4-triazole and 1,3,4-thiadiazole derivatives. Med Chem Res. 2013;22(7): 3134-3147.

DOI: 10.1007/s00044-012-0302-9.

Kadi AA, El-Azab AS, Alafeefy AM, Abdel-HamideSG. Synthesis and biological screening of some new substituted 2-Mercapto-4-(3H)-quinazolinone analogs as anticonvulsant agents. Az J Pharm Sci. 2006;34:135-155.

AlwanSM. Synthesis and preliminary antimicrobial activities of new arylideneamino-1,3,4-thiadiazole-(thio/dithio)-acetamido cephalosporanic acids. Molecules. 2012;17(1):1025-1038.

DOI: 10.3390/molecules17011025.

Baghel US, Kaur H, Chawla A, DhawanRK. Synthesis and antimicrobial evaluation of thiadiazole derivatives. Der Pharma Chem. 2014;6(2):66-69.

Hassanzadeh F, Jafari E, Hakimelahi GH, Rahmani Khajouei M, Jalali M, Khodarahmi GA. Antibacterial, antifungal and cytotoxic evaluation of some new quinazolinone derivatives. Res Pharm Sci. 2012;7(2):87-94.

Khodarahmi GA, Rahmani Khajouei M, Hakimelahi GH, Abedi D, Jafari E, HassanzadehF. Antibacterial, antifungal and cytotoxic evaluation of some new 2,3-disubstituted 4(3H)-quinazolinone derivatives. Res Pharm Sci. 2012;7(3):151-158.

Soleiman-Beigi M, Alikarami M, Hosseinzadeh T. One-pot synthesis of 2-alkylthio-1,3,4-oxadiazole and bis-(1,3,4-oxadiazole-2-yl)thio alkyl derivatives from acid hydrazides and CS2. Asian J Chem. 2013;25(9):4939-4942.

DOI: 10.14233/ajchem.2013.14148.

Rasool S, Rehman A, Abbasi MA, Gul S, Akhtar MN, Ahmad I, et al. Synthesis of N'-Substituted-2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio) acetohydrazide derivatives as suitable antibacterial agents. Trop J Pharm Res. 2015;14(6):1081-1088.

DOI: 10.4314/tjpr.v14i6.21.

Rad O, Tibor R, Duma M, Vlase L, Pîrnău A, Tiperciuc B, et al. Synthesis and antimicrobial activity of some 5-amino-2-mercapto-1,3,4-thiadiazole derivatives thioeters and Schiff bases. Studia Ubb Chemia. 2016;61:17-32.

Hassanzadeh F, Jafari E, Saeedi M, Saberi S. Synthesis and evaluation of thiadiazole-based antileishmanial agents. J Rep Pharm Sci. 2020;9(2):189-195.

DOI: 10.4103/jrptps.JRPTPS_3_20.

Hassanzadeh F, Jafari E, Zarabi M, Khodarahmi G, Vaseghi G. Synthesis, cytotoxic evaluation, and molecular docking studies of some new 1,3,4-oxadiazole-based compounds. Res Pharm Sci. 2020;15(5):454-462.

DOI: 10.4103/1735-5362.297848.

Sunil RJ, Pal S, Jayashree A. Molecular hybridization-an emanating tool in drug design. Med Chem. 2019;9(6):93-95.


  • There are currently no refbacks.

Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.